Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
| Published in: | Journal of Experimental & Clinical Cancer Research |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-06-01
|
| Online Access: | https://doi.org/10.1186/s13046-024-03104-w |
| _version_ | 1850034686551654400 |
|---|---|
| author | Jiaojiao Hao Wenhua Fan Yizhuo Li Ranran Tang Chunfang Tian Qian Yang Tianhua Zhu Chaoliang Diao Sheng Hu Manyu Chen Ping Guo Qian Long Changlin Zhang Ge Qin Wendan Yu Miao Chen Liren Li Lijun Qin Jingshu Wang Xiuping Zhang Yandong Ren Penghui Zhou Lijuan Zou Kui Jiang Wei Guo Wuguo Deng |
| author_facet | Jiaojiao Hao Wenhua Fan Yizhuo Li Ranran Tang Chunfang Tian Qian Yang Tianhua Zhu Chaoliang Diao Sheng Hu Manyu Chen Ping Guo Qian Long Changlin Zhang Ge Qin Wendan Yu Miao Chen Liren Li Lijun Qin Jingshu Wang Xiuping Zhang Yandong Ren Penghui Zhou Lijuan Zou Kui Jiang Wei Guo Wuguo Deng |
| author_sort | Jiaojiao Hao |
| collection | DOAJ |
| container_title | Journal of Experimental & Clinical Cancer Research |
| format | Article |
| id | doaj-art-d2b3541f8f65403bb7f85b1e46cf2f73 |
| institution | Directory of Open Access Journals |
| issn | 1756-9966 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | BMC |
| record_format | Article |
| spelling | doaj-art-d2b3541f8f65403bb7f85b1e46cf2f732025-08-20T00:34:39ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662024-06-014311510.1186/s13046-024-03104-wCorrection: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traitsJiaojiao Hao0Wenhua Fan1Yizhuo Li2Ranran Tang3Chunfang Tian4Qian Yang5Tianhua Zhu6Chaoliang Diao7Sheng Hu8Manyu Chen9Ping Guo10Qian Long11Changlin Zhang12Ge Qin13Wendan Yu14Miao Chen15Liren Li16Lijun Qin17Jingshu Wang18Xiuping Zhang19Yandong Ren20Penghui Zhou21Lijuan Zou22Kui Jiang23Wei Guo24Wuguo Deng25Institute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreNanjing Maternity and Child Health Care Hospital, Women’s Hospital of Nanjing Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCloud Health Genomics LtdCloud Health Genomics LtdState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer CentreInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityInstitute of Cancer Stem Cells and The Second Affiliated Hospital, Dalian Medical UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Centrehttps://doi.org/10.1186/s13046-024-03104-w |
| spellingShingle | Jiaojiao Hao Wenhua Fan Yizhuo Li Ranran Tang Chunfang Tian Qian Yang Tianhua Zhu Chaoliang Diao Sheng Hu Manyu Chen Ping Guo Qian Long Changlin Zhang Ge Qin Wendan Yu Miao Chen Liren Li Lijun Qin Jingshu Wang Xiuping Zhang Yandong Ren Penghui Zhou Lijuan Zou Kui Jiang Wei Guo Wuguo Deng Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title | Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title_full | Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title_fullStr | Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title_full_unstemmed | Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title_short | Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| title_sort | correction melatonin synergizes braf targeting agent vemurafenib in melanoma treatment by inhibiting inos htert signaling and cancer stem cell traits |
| url | https://doi.org/10.1186/s13046-024-03104-w |
| work_keys_str_mv | AT jiaojiaohao correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT wenhuafan correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT yizhuoli correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT ranrantang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT chunfangtian correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT qianyang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT tianhuazhu correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT chaoliangdiao correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT shenghu correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT manyuchen correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT pingguo correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT qianlong correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT changlinzhang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT geqin correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT wendanyu correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT miaochen correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT lirenli correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT lijunqin correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT jingshuwang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT xiupingzhang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT yandongren correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT penghuizhou correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT lijuanzou correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT kuijiang correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT weiguo correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits AT wuguodeng correctionmelatoninsynergizesbraftargetingagentvemurafenibinmelanomatreatmentbyinhibitinginoshtertsignalingandcancerstemcelltraits |